Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Nilotinib can cause skin issues like red bumps and hair loss.

Vitamin D protects skin cells from damage caused by captopril.

A new engineered treatment shows promise in curing heart fibrosis.

A man developed heart problems after using a baldness treatment for 4 months, suggesting that people with heart issues should avoid this treatment.

QLT0267 stops hair follicle cell growth and movement.

Propranolol affects heart rate and renin levels in minoxidil-treated patients.

Minoxidil sulfate, delivered through iontophoresis, can be used to treat hair loss.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Eye drops with β-blockers may cause hair loss.

Tofacitinib treatment for hair loss may worsen acne.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The diphosphonate was the most effective at preventing calcification in rats.